Journal of Psychosomatic Research
Volume 57, Issue 2 , Pages 123-131 , August 2004

Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients

  • Geir Smedslund

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +47-24-16-30-00; fax: +47-24-16-30-03
    • Department for Social Services Research, Norwegian Directorate for Health and Social Affairs, P.O. Box 8054 Dep., NO-0031, Oslo, Norway
    • ,
  • Gerd Inger Ringdal

      Affiliations

    • Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway

Received 27 November 2002 ,Accepted 3 September 2003.

References 

  1. American Cancer Society . Cancer Facts & Figures 2003. American Cancer Society, Inc, Surveillance Research; 2002; www.cancer.org
  2. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–543
  3. Gross J. Emotional expression in cancer onset and progression. Soc Sci Med. 1989;28:1239–1248
  4. Schneiderman N, Antoni MH, Saab PG, Ironson G. Health psychology: psychosocial and biobehavioral aspects of chronic disease management. Annu Rev Psychol. 2001;52:555–580
  5. Madigan M, Ziegler R, Benichou J, Byne C, Hoover R. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 1995;87:1681–1685
  6. Greer S. Psychological intervention. The gap between research and practice. Acta Oncol. 2002;41:238–243
  7. Classen C, Sephton SE, Diamond S, Spiegel D. Studies of life-extending psychosocial interventions. In:  Holland J editors. Textbook of psycho-oncology. New York: Oxford Univ Press; 1998;p. 730–742
  8. Baum A, Posluszny DM. Health psychology: mapping biobehavioral contributions to health and illness. Annu Rev Psychol. 1999;50:137–163
  9. De Boer M, Ryckman R, Pruyn J, Van den Borne H. Psychosocial correlates of cancer relapse and survival: a literature review. Patient Educ Couns. 1999;37:215–230
  10. Bleiker EM, VanderPloeg HM. Psychosocial factors in the etiology of breast cancer: review of a popular link. Patient Educ Couns. 1999;37:201–214
  11. Geyer S. Psychological factors in the development and course of malignant diseases. Cancer J. 1997;10:238–243
  12. Eysenck HJ. Cancer, personality and stress: prediction and prevention. Adv Behav Res Ther. 1994;16:167–215
  13. LeShan L. Psychological states as factors in the development of malignant disease: a critical review. J Natl Cancer Inst. 1959;22:1–18
  14. Bahnson C. Stress and cancer: the state of the art. Part 1. Psychosomatics. 1980;21:975–981
  15. Bahnson C. Stress and cancer: the state of the art. Part 2. Psychosomatics. 1981;22:207–220
  16. Schmale A, Iker H. Hopelessness as a predictor of cervical cancer. Soc Sci Med. 1971;5:95–100
  17. Jensen M. Psychobiological factors predicting the course of breast cancer. J Pers. 1987;55:317–342
  18. Dattore PJ, Shontz FC, Coyne L. Premorbid personality differentiation of cancer and non-cancer groups: a test of the hypothesis of cancer proneness. J Consult Clin Psych. 1980;48:388–394
  19. Jansen M, Muenz L. A retrospective study of personality variables associated with fibrocystic disease and breast cancer. J Psychosom Res. 1984;28:35–42
  20. Buddeberg C, Buddeberg-Fischer B, Schnyder U. Coping strategies and 10-year outcome in early breast cancer. J Psychosom Res. 1997;43:625–626
  21. Hagnell O. The premorbid personality of persons who develop cancer in a total population investigated in 1947 and 1957. Ann New Acad Sci. 1966;125:846–855
  22. Hahn R, Petiti D. Minnesota Multiphasic Personality Inventory—rated depression and incidence of breast cancer. Cancer. 1988;61:845–848
  23. Linkins R, Comstock G. Depressed mood and development of cancer. Am J Epidemiol. 1990;132:962–972
  24. Shekelle RB, Raynor WJ, Ostfeld AM, Garron DC, Bieliauskas LA, Liu SC, et al. Psychological depression and 17-year risk of death from cancer. Psychosom Med. 1981;43:117–125
  25. Eysenck HJ. The methodology of epidemiological studies of smoking. In: Smoking, personality, and stress. Psychosocial factors in the prevention of cancer and coronary heart disease. London: Springer-Verlag; 1991;p. 28–45
  26. Fox BH. Psychosocial factors in cancer incidence and prognosis. In:  Holland J editors. Textbook of psycho-oncology. New York: Oxford Univ Press; 1998;p. 110–124
  27. Schwartz R, Geyer S. Social and psychological differences between cancer and noncancer patients: cause or consequence of the disease?. Psychother Psychosom. 1984;41:195–199
  28. Meyer TJ, Mark MM. Effects of psychological interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol. 1995;14:101–108
  29. Shrock D, Palmer RF, Taylor B. Effects of a psychosocial intervention on survival among patients with stage I breast and prostate cancer: a matched case-control study. Altern Ther. 1999;5:49–55
  30. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989;2:888–891
  31. Kogon MM, Biswas A, Pearl D, Carlson R, Spiegel D. Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma. Cancer. 1997;80:225–230
  32. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990;8:356–364
  33. Fawzy FI, Canada AL, Fawzy NW. Malignant melanoma. Effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry. 2003;60:100–103
  34. Kuchler T, Henne-Bruns D, Rappat S, Graul J, Holst K, Williams JI, et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepato-Gastroenterol. 1999;46:322–335
  35. Ilnyckyj A, Farber J, Cheang M, Weinerman B. A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Phys Surg Can. 1994;27:93–96
  36. Cunningham A, Edmonds C, Jenkins G, Pollack H, Lockwood G, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-oncology. 1998;7:508–517
  37. Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al. The effect of group psychosocial support on survival in metastatic breast cancer. New Engl J Med. 2001;345:1719–1726
  38. House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988;241:540–545
  39. Baider L, Peretz T, Hadani PE, Koch U. Psychological intervention in cancer patients: a randomized study. Gen Hosp Psychiatry. 2001;23:272–277
  40. Spiegel D, Stroud P, Fyfe A. Complementary medicine. West J Med. 1998;168:241–247
  41. Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst. 2002;94:558–584
  42. Ross L, Boesen EH, Dalton SO, Johansen C. Mind and cancer: does psychosocial intervention improve survival and psychological well-being?. Eur J Cancer. 2002;38:1447–1457
  43. Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer patients. Cancer. 1982;49:1048–1055
  44. Gellert GA, Maxwell RM, Siegel BS. Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10-year follow-up study. J Clin Oncol. 1993;11:66–69
  45. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–2834
  46. Review Manager (RevMan) [Computer Program]. Version 4.2 for Windows. Oxford (England): Cochrane Collaboration; 2002;
  47. Hedges LV, Olkin I. Statistical methods for meta-analysis. Boston: Academic Press; 1985;
  48. Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558
  49. Eysenck HJ. Personality as a predictor of cancer and cardiovascular disease, and the application of behaviour therapy in prophylaxis. Eur J Psychiatry. 1987;1:29–41
  50. Grossarth-Maticek R, Eysenck H. Length of survival and lymphocyte percentage in women with mammary cancer as a function of psychotherapy. Psychol Rep. 1989;65:315–321
  51. Newton BW. The use of hypnosis in the treatment of cancer patients. Am J Clin Hypn. 1983;25:104–113
  52. Morgenstern H, Gellert GA, Walter SD, Ostfeld AM, Siegel BS. The impact of a psychosocial support program on survival with breast cancer: the importance of selection bias in program evaluation. J Chronic Dis. 1984;37:273–282
  53. Bagenal F, Easton D, Harris E, Chilvers C, McElwain T. Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet. 1990;336:606–610
  54. Edelman S, Lemon J, Bell DR, Kidman AD. Effects of group CBT on the survival time of patients with metastatic breast cancer. Psycho-oncology. 1999;8:474–481
  55. Grossarth-Maticek R. Social psychotherapy and course of the disease. First experiences with cancer patients. Psychother Psychosom. 1980;33:129–139
  56. Van der Ploeg HM. What a wonderful world it would be: a reanalysis of some of the work of Grossarth-Maticek. Psychol Inq. 1991;2:280–285
  57. McCorkle R, Strumpf NE, Nuamah IF, Adler DC, Cooley ME, Jepson C, et al. A specialized home care intervention improves survival among older post-surgical cancer patients. J Am Geriatr Soc. 2000;48:1707–1713
  58. Ratcliffe MA, Dawson AA, Walker LG. Eysenck personality inventory L-scores in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Psycho-oncology. 1995;4:39–45
  59. Walker L, Ratcliffe M, Dawson A. Relaxation and hypnotherapy: long term effects on the survival of patients with lymphoma. Psycho-oncology. 2000;9:355–356
  60. Walker M, Walker L, Simpson E, Hutcheon A, Sarkar T, Heys S, et al. Do relaxation and guided imagery improve survival in women with locally advanced breast cancer?. Psycho-oncology. 2000;9:355
  61. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993;50:681–689
  62. Fox BH. A hypothesis about Spiegel et al.'s 1989 paper on psychosocial intervention and breast cancer survival. Psycho-oncology. 1998;7:361–370
  63. Eysenck H. Behaviour therapy as an aid in the prevention of cancer and coronary heart disease. Scand J Behav Ther. 1988;17:171–188
  64. Grossarth-Maticek R, Eysenck H. Prophylactic effects of psychoanalysis on cancer-prone and coronary heart disease-prone probands, as compared with control groups and behaviour therapy groups. J Behav Ther Exp Psychiatry. 1990;21:91–99
  65. Grossarth-Maticek R, Eysenck H, Boyle G, Heeb J, Costa S, Diel I. Interaction of psychosocial and physical risk factors in the causation of mammary cancer, and its prevention through psychological methods of treatment. J Clin Psychol. 2000;56:33–50
  66. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000
  67. Spiegel D. Mind matters—group therapy and survival in breast cancer. New Engl J Med. 2001;345:1767

PII: S0022-3999(03)00575-0

doi: 10.1016/S0022-3999(03)00575-0

Journal of Psychosomatic Research
Volume 57, Issue 2 , Pages 123-131 , August 2004

Article Tools

* Image Usage & Resolution